The European Medicines Agency approved the use of injections twice a year to protect against the human immunodeficiency virus, he said علما عنه أنه أنه على على تحميل تنزيل فيروس.
The European Union’s Medicines Regulatory Authority said in its statement on Friday that its reviews of the drug “linacabavir” sold in Europe شركة “جيليد صينسيز” بالاسم التجاري “يزتوجو” showed that the property is “strongly functional” and “it is considered among the health benefits” the great public”. Until the approval of the European Commission on the Authority’s guidelines, the property will be allowed to be used in all 27 European Union countries.
Studies conducted last year indicate that linacavir is already used to treat people infected with HIV the human being, active 100% in the endowment of the women and men.
اترك تعليقاً